India, Sept. 18 -- image credit- freepik

In a significant step toward combating India's growing diabetes burden, Sun Life Global Solutions (SLGS), the Global Capability Centre of Sun Life-a leading international insurance and asset management company-has announced a groundbreaking research collaboration with the Indian Institute of Technology Madras (IIT-M).

The joint initiative is focused on transforming early diagnosis and management of type 2 diabetes through the identification of Pancreastatin as a novel biomarker, along with genetic testing.The research, led by Dr Nitish R. Mahapatra, Professor, Department of Biotechnology and BJM School of Biosciences at IIT Madras, aims to establishPancreastatin as a reliable early indicator for ...